On June 30, 2023, NeuBase Therapeutics, Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.378 USD | -3.20% | -6.67% | -48.93% |
26/03 | Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading | MT |
26/03 | US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings | MT |
1st Jan change | Capi. | |
---|---|---|
-48.93% | 1.42M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- NBSE Stock
- News NeuBase Therapeutics, Inc.
- NeuBase Therapeutics, Inc. announced that it has received $3.512751 million in funding